Description
Letromina
Specification
Common | |
Active substance | Letrozole Citrate |
Indications | Letromina is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer |
Dosage | |
Quantity | |
Unit | |
Time | |
Potency | |
Quantity | 2,5 |
Unit | Milligram |
Packaging | |
Quantity | 30 |
Unit | Tablet |
Type | Carton |
Presentation | Each carton contains 30 tablets of 2.5mg each |